Thyroid
Molecular diagnostics and targeted therapies, such as tyrosine kinase inhibitors, have significantly improved the prognosis of advanced and recurrent thyroid cancers.
HEALTH DAY
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of Treatment
THURSDAY, Jan. 30, 2025 (HealthDay News) — The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1
February 4, 2025
HEALTH DAY
No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer
WEDNESDAY, Jan. 22, 2025 (HealthDay News) — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an
January 26, 2025
